超声引导下经皮射频消融治疗小肝癌患者疗效及预后分析*

doi:10.3969/j.issn.1672-5069.2019.01.033

摘要/Abstract

摘要： 目的比较超声引导下经皮射频消融与肝切除术治疗小肝癌患者的疗效及分析影响生存的危险因素。方法 2011年1月~2015年4月在我院接受治疗的107例肝细胞癌（HCC）患者,接受超声引导下射频消融治疗58例,接受肝叶切除术治疗49例。术后随访3年,采用Cox单因素和多因素回归分析影响HCC患者生存的独立危险因素。结果治疗后,射频消融患者血清ALT水平显著低于肝切除术组（P<0.05）,而血清ALB水平显著高于肝切除术组（P<0.05）;两组术后并发症发生率（10.3%对16.3%）比较,差异无统计学意义（P>0.05）;射频消融治疗患者1 a、2 a和3 a总生存率分别为84.5%（49/58）、65.5%（38/58）和44.8%（26/58）,而肝切除术组则分别为85.7%（42/49）、67.3%（33/49）和46.9%（23/49）,差异不具有统计学意义（x²=0.032,P=0.859;x²=0.040,P=0.842;x²=0.048,P=0.827）; Cox单因素分析结果显示肿瘤数目（HR=0.372,95%CI:0.105~0.876,P=0.033）与HCC患者无瘤生存时间有关,而血清AFP水平（HR=3.043,95%CI:1.007~5.248,P=0.035）、肿瘤数目（HR=0.871,95%CI:0.344~0.902,P=0.401）和肿瘤直径（HR=1.631,95%CI:1.273~3.045,P=0.005）与HCC患者总生存时间有关;Cox多因素回归分析结果显示肿瘤数目多（HR=0.087,95%CI:0.045~0.498,P=0.009）是影响HCC患者无瘤生存的独立危险因素,而肿瘤分化低（HR=2.974,95%CI:1.865~4.097,P=0.046）、肿瘤数目多（HR=0.062,95%CI:0.033~0.378,P=0.002）和肿瘤直径大（HR=2.216,95%CI:1.778~5.026,P=0.007）是影响HCC患者总生存时间的独立危险因素。结论超声引导下经皮射频消融治疗与肝切除术治疗小肝癌患者的临床疗效相当,但射频消融治疗创伤小,术后恢复快,对肝功能的影响小。

关键词: 肝细胞癌, 射频消融, 肝切除术, 疗效, 预后

Abstract: Objective To compare the efficacy of ultrasound-guided percutaneous radiofrequency ablation and hepatectomy in treatment of patients with hepatocellular carcinoma （HCC） of less than 3 cm diameters and to analyze the impacting factors of prognosis. Methods A total of 107 patients with HCC were recruited in our hospital between January 2011 and April 2015,and 58 patients with HCC received US-guided RPA,and 49 underwent hepatectomy. The independent risk factors affecting their survival was analyzed by Cox univariate and multivariate analysis. Results After treatment,serum ALT level in patients receiving radiofrequency ablation was significantly lower than that in patients receiving hepatectomy （P<0.05）,while serum albumin level was significantly higher than that in hepatectomy group （P<0.05）;the incidences of post-operational complications in the two groups （10.3% vs. 16.3%,P>0.05） were not statistically significantly different;the 1 a,2 a and 3 a overall survival（OS） rates in PRA-treated patients were 84.5%,65.5% and 44.8%,not significantly different as compared to 85.7%,67.3% and 46.9% in hepatectomy-treated patients （x²=0.032,P=0.859;x²=0.040,P=0.842;x²=0.048,P=0.827）;Cox univaritate analysis showed that tumor number （HR=0.372,95%CI:0.105-0.876,P=0.033） was related to the disease-free survival（DFS）,while serum AFP level（HR=3.043,95%CI:1.007-5.248,P=0.035）,tumor number （HR=0.871,95%CI:0.344-0.902,P=0.401） and tumor diameter （HR=1.631,95%CI:1.273-3.045,P=0.005） were related to the OS;Cox multivariate analysis showed that more than one tumor number （HR=0.087,95%CI:0.045-0.498,P=0.009） was the risk factor affecting the DFS,while lower tumor differentiation（HR=2.974,95%CI:1.865-4.097,P=0.046）,multiple tumor （HR=0.062,95%CI:0.033-0.378,P=0.002） and large tumor diameter （HR=2.216,95%CI:1.778-5.026,P=0.007） were the risk factors affecting the OS of patients with HCC. Conclusions Ultrasound-guided percutaneous radiofrequency ablation and hepatectomy are efficient in treating patients with HCC,while the patients undergoing radiofrequency ablation might have little trauma,less liver injuries and recover rapidly.

Key words: Hepatoma, Radiofrequency ablation, Hepatectomy, Efficacy, Prognosis

马履翔, 张雪松. 超声引导下经皮射频消融治疗小肝癌患者疗效及预后分析^*[J]. 实用肝脏病杂志, 2019, 22(1): 125-128.

Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.

参考文献

[1] Kihara K,Endo K,Suzuki K,et al.Isolated port-site metastasis of hepatocellular carcinoma after laparoscopic liver resection. Asian J Endosc Surg,2017,10(2):191-193.
[2] Yazici P,Akyuz M,Yigitbas H,et al.A comparison of perioperative outcomes in elderly patients with malignant liver tumors undergoing laparoscopic liver resection versus radiofrequency ablation. Surg Endosc,2017,31(3):1269-1274.
[3] 孙启峰,赵志强,周童,等. 腹腔镜肝部分切除术治疗肝癌患者血清肿瘤标志物的变化.实用肝脏病杂志,2018,21(1):121-122.
[4] 洪德飞,范小明,罗祖炎,等. 经皮微波或射频消融肝实质分隔联合门静脉栓塞计划性肝切除术治疗余肝体积不足肝癌及胆管癌3例报告. 中华肿瘤杂志,2017,39(7):96-101.
[5] Crocetti L.Radiofrequency ablation versus resection for small hepatocellular carcinoma:are randomized controlled trials still needed. Radiology,2018,287(2):473-475.
[6] 王鹤,董家鸿,卢实春,等. 手术切除与射频消融治疗原发性肝癌患者预后比较. 实用肝脏病杂志,2017,20(3):337-340.
[7] Meijerink MR,Puijk RS,van Tilborg AAJM,et al. Radiofrequency and microwave ablation compared to systemic chemotherapy and to partial hepatectomy in the treatment of colorectal liver metastases:a systematic review and meta-analysis. Cardiovasc Intervent Radiol,2018,41(8):1189-1204.
[8] Jiao LR,Hakim DN,Gall TM,et al.A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection. Hepatobiliary Surg Nutr,2016,5(4):382-387.
[9] Lai C,Jin RA,Liang X,et al.Comparison of laparoscopic hepatectomy,percutaneous radiofrequency ablation and open hepatectomy in the treatment of small hepatocellular carcinoma. J Zhejiang Univ Sci B,2016,17(3):236-246.
[10] Song J,Wang Y,Ma K,et al.Laparoscopic hepatectomy versus radiofrequency ablation for minimally invasive treatment of single,small hepatocellular carcinomas. Surg Endosc,2016,30(10):4249-4257.
[11] Santambrogio R,Bruno S,Kluger MD,et al.Laparoscopic ablation therapies or hepatic resection in cirrhotic patients with small hepatocellular carcinoma. Dig Liver Dis,2016,48(2):189-196.
[12] Vavra P,Penhaker M,Jurcikova J,et al.Semi-spherical radiofrequency bipolar device-A new technique for liver resection:Experimental in vivo study on the porcine model. Technol Cancer Res Treat,2015,14(5):573-582.
[13] 徐治军,许戈良,马金良,等. 超声引导下经皮射频消融与腹腔镜肝切除术治疗原发性小肝癌的对比研究.中国普通外科杂志,2017,26(1):18-24.
[14] Eisele RM,Chopra SS,Kubale R,et al.Radiofrequency ablation for treatment of colorectal liver metastases:scientific evidence and clinical reality. Zentralbl Chir,2014,139(2):193-202.
[15] Hof J,Joosten HJ,Havenga K,et al.Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. PLoS One,2018,13(3):e0193385.
[16] Rong Z,Lu Q,Yan J.Totally laparoscopic radiofrequency-assisted liver partition with portal vein ligation for hepatocellular carcinoma in cirrhotic liver. Medicine(Baltimore),2017,96(51):e9432.
[17] Li J,Xi H,Cui J,et al.Minimally invasive surgery as a treatment option for gastric cancer with liver metastasis:a comparison with open surgery. Surg Endosc,2018,32(3):1422-1433.
[18] Mohkam K,Dumont PN,Manichon AF,et al.No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm. J Hepatol,2018,68(6):1172-1180.
[19] Quesada R,Moreno A,Poves I,et al.The impact of radiofrequency-assisted transection on local hepatic recurrence after resection of colorectal liver metastases. Surg Oncol,2017,26(3):229-235.

超声引导下经皮射频消融治疗小肝癌患者疗效及预后分析^*

Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	朱娅鸽, 刘锦峰. 丁二磺酸腺苷蛋氨酸联合复方甘草酸苷治疗酒精性肝硬化患者疗效及其对血清BGP水平的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 872-875.
[2]	曹策, 郁义星, 王贝贝, 赵卫峰. 增强磁共振成像联合血清甲胎蛋白和脱-γ-羧基凝血酶原诊断肝细胞癌临床价值探讨[J]. 实用肝脏病杂志, 2019, 22(6): 896-899.
[3]	金震, 周晓春, 马红霞. 椎旁阻滞联合全身麻醉对肝血管瘤切除术患者疼痛及术后恢复的影响^*[J]. 实用肝脏病杂志, 2019, 22(6): 908-911.
[4]	黎秋曦, 贾健锋, 黄锐. 区段肝蒂肝切除术与B超引导下肝切除术治疗肝胆管结石患者临床价值分析^*[J]. 实用肝脏病杂志, 2019, 22(6): 916-919.
[5]	朱玉成, 闫家微, 孙景坤, 张秋月. 慢加急性肝衰竭患者血清二胺氧化酶水平及其临床意义探讨*[J]. 实用肝脏病杂志, 2019, 22(5): 672-675.
[6]	巴正武, 栗海龙, 杨慧. 能谱CT成像定量评估Budd-Chiari综合征患者TIPS术治疗前后肝功能状态临床价值研究*[J]. 实用肝脏病杂志, 2019, 22(5): 680-683.
[7]	朱俊, 丁莹, 王世清, 张野, 刘野, 刘泽刚. 围手术期应用乌司他丁治疗对肝细胞癌患者肝切除术后外周血Th22细胞百分比和血浆白细胞介素-22的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 720-723.
[8]	王刚, 赵洪波, 朱亚玲, 蒋保三, 张越美, 刁勇. 基于数据库分析肝细胞癌细胞XPO5基因水平变化及其临床意义*[J]. 实用肝脏病杂志, 2019, 22(5): 724-727.
[9]	张志成, 袁广庆, 莫灿均. 肝动脉栓塞术治疗三种类型肝血管瘤患者疗效及安全性分析*[J]. 实用肝脏病杂志, 2019, 22(5): 736-739.
[10]	白一春, 邓霁红, 梅小平. 影响聚乙二醇干扰素α-2b治疗慢性乙型肝炎患者疗效的多因素分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 490-493.
[11]	庄太平, 尹杨艳, 谢蔓芳, 冯乃超, 陈彩华. 人巨细胞病毒感染与肝炎综合征婴儿临床特点比较^*[J]. 实用肝脏病杂志, 2019, 22(4): 514-517.
[12]	严玲玲, 胡东辉, 黄艳芳. 腺苷蛋氨酸联合多烯磷酯酰胆碱治疗妊娠期肝内胆汁淤积症患者临床疗效初步研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 530-533.
[13]	彭思璐, 刘冰, 孙宏, 林剑, 潘志颖, 邓存良. HBV相关慢加急性肝衰竭患者预后及其影响因素分析^*[J]. 实用肝脏病杂志, 2019, 22(4): 545-548.
[14]	戴青云, 王润东, 荚卫东. 术前预后营养指数评估肝细胞癌患者肝切除术后早期肿瘤复发价值探讨^*[J]. 实用肝脏病杂志, 2019, 22(4): 561-564.
[15]	杨富存, 尚怀学, 盖永浩. 钆塞酸二钠增强磁共振扫描诊断肝脏局灶性病变研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 577-580.